3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gynecologic
1
Genitourinary
1
Breast
1
Conditions
Testicular Germ Cell Tumor
1
Sarcoma
1
Pulmonary Disease, Chronic Obstructive
1
Ovarian Neoplasms
1
Neoplasms
1
Lung Diseases, Interstitial
1
Dyspnea
1
Breast Neoplasms
1
Interventions
Specimen Handling
10
Biopsy
9
Magnetic Resonance Spectroscopy
8
pembrolizumab
6
Cyclophosphamide
6
X-Rays
5
Phantoms, Imaging
5
Doxorubicin
5
Nuclear Medicine Department, Hospital
4
liposomal doxorubicin
3
fludarabine
3
atezolizumab
3
Radiation
3
Irinotecan
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
fludarabine phosphate
2
ensartinib
2
anlotinib
2
Temozolomide
2
Surveys and Questionnaires
2
Radiotherapy
2
Ifosfamide
2
Fluorodeoxyglucose F18
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma
×
Hypnosis
×
30 days
×
Clear all
NCT07614620
2026-05-29
HYPNO-AJA2
Institut Bergonié
Phase NA
Not yet recruiting
70 enrolled